Periosteum as a source of mesenchymal stem cells: The effects of TGF-β3 on chondrogenesis

Clinics

Volumn 66, Issue 3, 2011, Pages 487-492

  de Mara, Cristiane Sampaio ^a   Sartori, Angélica Rossi ^a   Duarte, Adriana Silva ^a   Andrade, Andre Luis Lugani ^a   Pedro, Marcio Amaral Camargo ^a   Coimbra, Ibsen Bellini ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Chondrogenesis; High density Culture; Mesenchymal Stem Cells; Monolayer Culture; Periosteum

Indexed keywords

COLLAGEN TYPE 2; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CHONDROGENESIS; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; HUMAN; MESENCHYMAL STEM CELL; MIDDLE AGED; PERIOSTEUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROGENESIS; COLLAGEN TYPE II; GENE EXPRESSION; HUMANS; MESENCHYMAL STEM CELLS; MIDDLE AGED; PERIOSTEUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA3;

EID: 79957587096     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000300022     Document Type: Article

References (40)

1. Hunziker EB. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage. 2002;10:432-63, doi: 10.1053/joca.2002.0801.
2. Schaefer D, Martin I, Jundt G, Seidel J, Heberer M, Grodzinsky A, et al. Tissue-engineered composites for the repair of large osteochondral defects. Arthritis Rheum. 2002;46:2524-34, doi: 10.1002/art.10493.
3. De Bari C, Dell'accio F. Mesenchymal stem cells in rheumatology: a regenerative approach to joint repair. Clin Sci (Lond). 2007;113:339-48, doi: 10.1042/CS20070126.
4. De Bari C, Dell'Accio F, Vanlauwe J, Eyckmans J, Khan IM, Archer CW, et al. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum. 2006; 54:1209-21, doi: 10.1002/art.21753.
5. Mara CS, Duarte AS, Sartori A, Luzo AC, Saad ST, Coimbra IB. Regulation of chondrogenesis by transforming growth factor-ss3 and insulin-like growth factor-1 from human mesenchymal umbilical cord blood cells. J Rheumatol. 2010;37:1519-26, doi: 10.3899/jrheum.091169.
6. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331:889-95.
7. Choi YS, Lim SM, Shin HC, Lee CW, Kim SL, Kim DI. Chondrogenesis of human periosteum-derived progenitor cells in atelocollagen. Biotechnol Lett. 2007;29:323-9, doi: 10.1007/s10529-006-9240-2.
8. O'Driscoll SW. Articular cartilage regeneration using periosteum. Clin Orthop Relat Res. 1999 (367 Suppl): S186-203, doi: 10.1097/00003086-199910001-00020.
9. O'Driscoll SW, Meisami B, Miura Y, Fitzsimmons JS. Viability of periosteal tissue obtained postmortem. Cell Transplant. 1999;8:611-6.
10. Ochi M, Uchio Y, Kawasaki K, Wakitani S, Iwasa J. Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defects of the knee. J Bone Joint Surg Br. 2002;84:571-8, doi: 10. 1302/0301-620X.84B4.11947.
11. Lin Z, Fitzgerald JB, Xu J, Willers C, Wood D, Grodzinsky AJ, et al. Gene expression profiles of human chondrocytes during passaged monolayer cultivation. J Orthop Res. 2008 10.
12. Darling EM, Athanasiou KA. Rapid phenotypic changes in passaged articular chondrocyte subpopulations. J Orthop Res. 2005;23:425-32, doi: 10.1016/j.orthres.2004.08.008.
13. DeLise AM, Fischer L, Tuan RS. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage. 2000;8:309-34, doi: 10. 1053/joca.1999.0306.
14. Modarresi R, Lafond T, Roman-Blas JA, Danielson KG, Tuan RS, Seghatoleslami MR. N-cadherin mediated distribution of beta-catenin alters MAP kinase and BMP-2 signaling on chondrogenesis-related gene expression. J Cell Biochem. 2005;95:53-63.
15. Woodward WA, Tuan RS. N-Cadherin expression and signaling in limb mesenchymal chondrogenesis: stimulation by poly-L-lysine. Dev Genet. 1999;24:178-87, doi: 10.1002/(SICI)1520-6408(1999)24:1/2, 178:: AIDDVG16.3.0. CO;2-M.
16. Jansen EJ, Emans PJ, Guldemond NA, van Rhijn LW, Welting TJ, Bulstra SK, et al. Human periosteum-derived cells from elderly patients as a source for cartilage tissue engineering? J Tissue Eng Regen Med. 2008;2:331-9, doi: 10.1002/term.100.
17. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood). 2001;226:507-20.
18. Neumann K, Dehne T, Endres M, Erggelet C, Kaps C, Ringe J, et al. Chondrogenic differentiation capacity of human mesenchymal progenitor cells derived from subchondral cortico-spongious bone. J Orthop Res. 2008 7.
19. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998;238:265-72, doi: 10.1006/excr.1997.3858.
20. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. Chondrogenic differentiation of cultured human mesenchymal stem cells from row. Tissue Eng. 1998 Winter;4:415-28, doi: 10.1089/ten.1998.4. 415.
21. Stokes DG, Liu G, Dharmavaram R, Hawkins D, Piera-Velazquez S, Jimenez SA. Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocytespecific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors. Biochem J. 2001;360:461-70, doi: 10.1042/ 0264-6021:3600461.
22. Borus T, Thornhill T. Unicompartmental knee arthroplasty. J Am Acad Orthop Surg. 2008;16:9-18.
23. Steadman JR, Rodkey WG, Rodrigo JJ. Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin Orthop Relat Res. 2001 (391 Suppl): S362-9, doi: 10.1097/00003086-200110001-00033.
24. Bartha L, Vajda A, Duska Z, Rahmeh H, Hangody L. Autologous osteochondral mosaicplasty grafting. J Orthop Sports Phys Ther. 2006;36: 739-50.
25. Bodo G, Hangody L, Modis L, Hurtig M. Autologous osteochondral grafting (mosaic arthroplasty) for treatment of subchondral cystic lesions in the equine stifle and fetlock joints. Vet Surg. 2004;33:588-96, doi: 10. 1111/j.1532-950X.2004.04096.x.
26. Hangody L. The mosaicplasty technique for osteochondral lesions of the talus. Foot Ankle Clin. 2003;8:259-73, doi: 10.1016/S1083-7515(03)00017-2.
27. Hangody L, Fules P. Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience. J Bone Joint Surg Am. 2003;85-A Suppl 2:25-32.
28. Kish G, Modis L, Hangody L. Osteochondral mosaicplasty for the treatment of focal chondral and osteochondral lesions of the knee and talus in the athlete. Rationale, indications, techniques, and results. Clin Sports Med. 1999;18:45-66, vi., doi: 10.1016/S0278-5919(05)70129-0
29. Hangody L, Feczko P, Bartha L, Bodo G, Kish G. Mosaicplasty for the treatment of articular defects of the knee and ankle. Clin Orthop Relat Res. 2001 (391 Suppl): S328-36, doi: 10.1097/00003086-200110001-00030.
30. Hangody L, Rathonyi GK, Duska Z, Vasarhelyi G, Fules P, Modis L. Autologous osteochondral mosaicplasty. Surgical technique. J Bone Joint Surg Am. 2004;86-A Suppl 1:65-72.
31. Poole AR. What type of cartilage repair are we attempting to attain? J Bone Joint Surg Am. 2003;85-A Suppl 2:40-4.
32. Gooding CR, Bartlett W, Bentley G, Skinner JA, Carrington R, Flanagan A. A prospective, randomised study comparing two techniques of autologous chondrocyte implantation for osteochondral defects in the knee: Periosteum covered versus type I/III collagen covered. Knee. 2006;13:203-10, doi: 10.1016/j.knee.2006.02.011.
33. Brittberg M, Sjogren-Jansson E, Thornemo M, Faber B, Tarkowski A, Peterson L, et al. Clonal growth of human articular cartilage and the functional role of the periosteum in chondrogenesis. Osteoarthritis Cartilage. 2005;13:146-53, doi: 10.1016/j.joca.2004.10.020.
34. De Bari C, Dell'Accio F, Luyten FP. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum. 2001;44:85-95, doi: 10.1002/1529-0131(200101)44:1, 85:: AID-ANR12.3.0.CO;2-6.
35. Hsieh PC, Thanapipatsiri S, Anderson PC, Wang GJ, Balian G. Repair of full-thickness cartilage defects in rabbit knees with free periosteal graft preincubated with transforming growth factor. Orthopedics. 2003;26:393-402.
36. Reinholz GG, Fitzsimmons JS, Casper ME, Ruesink TJ, Chung HW, Schagemann JC, et al. Rejuvenation of periosteal chondrogenesis using local growth factor injection. Osteoarthritis Cartilage. 2009;17:723-34, doi: 10.1016/j.joca.2008.10.011.
37. Koga H, Muneta T, Nagase T, Nimura A, Ju YJ, Mochizuki T, et al. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit. Cell Tissue Res. 2008 17.
38. Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther. 2003;5:32-45, doi: 10.1186/ar614.
39. Oberlender SA, Tuan RS. Expression and functional involvement of Ncadherin in embryonic limb chondrogenesis. Development. 1994;120:177-87.
40. Denker AE, Haas AR, Nicoll SB, Tuan RS. Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures. Differentiation. 1999;64:67-76, doi: 10.1046/j.1432-0436.1999.6420067.x.